NCT04308590: An ongoing trial by Corcept Therapeutics
This trial is ongoing. It must report results 6 months, 1 week from now.
Full data
| Full entry on ClinicalTrials.gov | NCT04308590 |
|---|---|
| Title | Glucocorticoid Receptor Antagonism in the Treatment of Hypercortisolism in Patients With Cortisol-Secreting Adrenal Adenomas or Hyperplasia: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Relacorilant |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | July 27, 2020 |
| Completion date | Oct. 8, 2024 |
| Required reporting date | Oct. 8, 2025, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |